Banrida Wahlang Selected Research

3,4,5,3',4'-pentachlorobiphenyl

8/2022	Multiomics analysis of the impact of polychlorinated biphenyls on environmental liver disease in a mouse model.
12/2020	Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.
7/2020	Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.
2/2019	Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction.
1/2018	Dioxin-like PCB 126 Increases Systemic Inflammation and Accelerates Atherosclerosis in Lean LDL Receptor-Deficient Mice.
12/2017	Editor's Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model.
1/2017	A compromised liver alters polychlorinated biphenyl-mediated toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Banrida Wahlang Research Topics

Disease

16	Non-alcoholic Fatty Liver Disease 08/2022 - 07/2012
14	Fatty Liver 08/2022 - 02/2013
13	Inflammation (Inflammations) 08/2022 - 09/2014
8	Obesity 01/2021 - 07/2012
6	Liver Diseases (Liver Disease) 08/2022 - 04/2019
6	Fibrosis (Cirrhosis) 08/2022 - 01/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 01/2016
4	Atherosclerosis 02/2022 - 09/2016
4	Insulin Resistance 01/2022 - 09/2013
3	Necrosis 01/2022 - 06/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2017 - 07/2012
2	Neoplasms (Cancer) 01/2022 - 12/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2019 - 02/2016
1	Pneumonia (Pneumonitis) 02/2022
1	Glucose Intolerance 02/2022
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Hyperglycemia 01/2021
1	Hemangiosarcoma (Angiosarcoma) 01/2020
1	Alcoholic Hepatitis 12/2019
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2019
1	Dyslipidemias (Dyslipidemia) 07/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Body Weight (Weight, Body) 12/2017
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2017
1	Wasting Syndrome (Wasting Disease) 01/2017
1	Vascular Diseases (Vascular Disease) 09/2016
1	Alcoholic Fatty Liver 02/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 08/2014

Drug/Important Bio-Agent (IBA)

20	Polychlorinated Biphenyls (PCBs)IBA 08/2022 - 07/2012
10	Environmental Pollutants (Pollutants, Environmental)IBA 02/2020 - 06/2015
8	Persistent Organic PollutantsIBA 08/2022 - 07/2012
7	3,4,5,3',4'-pentachlorobiphenylIBA 08/2022 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2016
6	DioxinsIBA 08/2022 - 06/2015
6	XenobioticsIBA 01/2021 - 08/2014
5	LipidsIBA 08/2022 - 06/2015
4	CytokinesIBA 02/2022 - 02/2016
4	aroclor 1260IBA 01/2019 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2018
3	MicroRNAs (MicroRNA)IBA 08/2022 - 09/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2019
3	EnzymesIBA 04/2019 - 07/2012
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2020
2	ProteomeIBA 08/2022 - 07/2020
2	LDL Receptors (LDL Receptor)IBA 02/2022 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2013
2	Volatile Organic CompoundsIBA 12/2021 - 05/2020
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 07/2020
2	MetalsIBA 07/2020 - 02/2020
2	LeptinIBA 05/2020 - 01/2019
2	InsecticidesIBA 02/2020 - 06/2015
2	Vinyl Chloride (Chloroethylene)IBA 01/2020 - 02/2013
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019 - 02/2016
2	AntioxidantsIBA 01/2018 - 07/2012
2	trimethyloxamine (trimethylamine N-oxide)IBA 12/2017 - 01/2016
1	K-18 conjugate (K18)IBA 01/2022
1	Keratin-18 (Keratin 18)IBA 01/2022
1	Constitutive Androstane ReceptorIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	AdiponectinIBA 01/2021
1	PhosphoproteinsIBA 07/2020
1	Heavy MetalsIBA 05/2020
1	Indicators and Reagents (Reagents)IBA 05/2020
1	Benzene (Benzole)IBA 05/2020
1	TolueneIBA 05/2020
1	CadmiumIBA 05/2020
1	Alanine Transaminase (SGPT)IBA 02/2020
1	MercuryIBA 02/2020
1	RoflumilastIBA 12/2019
1	EndotoxinsIBA 12/2019
1	Phosphodiesterase 4 InhibitorsIBA 12/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 12/2019
1	AcidsIBA 04/2019
1	AdipokinesIBA 04/2019
1	Uric Acid (Urate)IBA 02/2019
1	Amino Acids FDA Link 02/2019
1	Choline (Choline Chloride)IBA 02/2019
1	Methionine (L-Methionine)FDA Link 02/2019
1	Glutathione (Reduced Glutathione)IBA 02/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2017
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2017
1	AroclorsIBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	oil red OIBA 06/2015
1	SolventsIBA 06/2015
1	PesticidesIBA 06/2015
1	HerbicidesIBA 06/2015
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 09/2014
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 09/2014
1	LigandsIBA 08/2014
1	2,4,5,2',4',5'-hexachlorobiphenylIBA 09/2013

Therapy/Procedure

1	Therapeutics 09/2018